Valuation: Bayer AG

Market Cap 46.29B 53.31B 43.16B 39.65B 74.99B 5,071B 75.81B 509B 199B 2,535B 200B 196B 8,400B P/E 2026 *
19.9x
P/E 2027 * 15.2x
Enterprise Value 78.13B 89.98B 72.85B 66.92B 127B 8,560B 128B 859B 336B 4,279B 338B 331B 14,177B EV / Sales 2026 *
1.71x
EV / Sales 2027 * 1.59x
Free-Float
100%
Yield 2026 *
0.29%
Yield 2027 * 1.26%
1 week+2.53%
Current month+0.86%
1 month-7.15%
3 months+29.94%
6 months+10.30%
Current year+36.76%
1 week 205
Extreme 205
214.1
1 month 205
Extreme 205
226.7
3 years 78.97
Extreme 78.97
241
Manager TitleAgeSince
Chief Executive Officer 60 31/05/2023
Director of Finance/CFO 57 31/05/2026
Chief Tech/Sci/R&D Officer 59 31/01/2021
Director TitleAgeSince
Director/Board Member 56 31/03/2012
Director/Board Member 60 31/03/2017
Chairman 68 27/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
+2.68%-0.15%+76.89%-10.12% 53.26B
-0.87%-8.81%+44.75%+147.65% 1T
-0.20%-4.83%+48.42%+50.17% 613B
-0.35%-7.24%+23.81%+65.27% 433B
+0.48%-2.77%+40.27%+34.96% 350B
+0.08%-4.45%+31.74%+39.89% 292B
+2.09%-9.27%+5.42%+7.61% 239B
+1.75%-8.29%-1.73%-42.05% 206B
+2.65%-1.05%+28.82%+59.89% 204B
+1.35%-0.96%+16.17%+69.08% 163B
Average +0.85%-3.88%+31.46%+42.23% 388.94B
Weighted average by Cap. +0.27%-4.34%+34.24%+69.41%

Financials

2026 *2027 *
Net sales 45.61B 52.53B 42.53B 39.07B 73.89B 4,997B 74.7B 501B 196B 2,498B 197B 193B 8,277B 46.75B 53.84B 43.59B 40.04B 75.73B 5,121B 76.56B 514B 201B 2,560B 202B 198B 8,483B
Net income 2.18B 2.51B 2.03B 1.86B 3.53B 239B 3.57B 23.93B 9.36B 119B 9.42B 9.21B 395B 2.92B 3.36B 2.72B 2.5B 4.73B 320B 4.78B 32.1B 12.55B 160B 12.63B 12.35B 530B
Net Debt 31.84B 36.67B 29.69B 27.27B 51.58B 3,488B 52.15B 350B 137B 1,744B 138B 135B 5,778B 28.23B 32.51B 26.32B 24.18B 45.73B 3,093B 46.23B 310B 121B 1,546B 122B 119B 5,123B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Date Price Change
04/08/26 PLN 210.50 +2.68%
03/08/26 PLN 205.00 -1.77%
31/07/26 PLN 208.70 0.00%
30/07/26 PLN 208.70 +1.66%
29/07/26 PLN 205.30 0.00%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
47.12EUR
Average target price
54.92EUR
Spread / Average Target
+16.55%

Quarterly revenue - Rate of surprise